These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1556455)

  • 21. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type beta.
    Mustoe TA; Landes A; Cromack DT; Mistry D; Griffin A; Deuel TF; Pierce GF
    Surgery; 1990 Aug; 108(2):324-9; discussion 329-30. PubMed ID: 2382228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental study of proliferation effects of platelet derived wound healing factor on tissue cells of wound].
    Zhang Y; Chen R; Zhu X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jul; 12(4):201-4. PubMed ID: 10437066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells.
    Ogino Y; Ayukawa Y; Kukita T; Koyano K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protein and polypeptide growth factors--platelet-derived and macrophage-derived growth factors].
    Kaji K; Miwa A
    Nihon Rinsho; 1986 Jan; 44(1):57-63. PubMed ID: 3007808
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of factors important in atherosclerotic occlusion and restenosis.
    Schwartz SM; Reidy MA; O'Brien ER
    Thromb Haemost; 1995 Jul; 74(1):541-51. PubMed ID: 8578522
    [No Abstract]   [Full Text] [Related]  

  • 26. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts.
    Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J
    J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of growth factors in tissue repair.
    Lynch SE
    Prog Clin Biol Res; 1991; 365():341-57. PubMed ID: 1713697
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion.
    Moulin V; Lawny F; Barritault D; Caruelle JP
    Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):961-71. PubMed ID: 9763200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro.
    Kilian O; Flesch I; Wenisch S; Taborski B; Jork A; Schnettler R; Jonuleit T
    Eur J Med Res; 2004 Jul; 9(7):337-44. PubMed ID: 15337634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy.
    Pierce GF; Brown D; Mustoe TA
    J Lab Clin Med; 1991 May; 117(5):373-82. PubMed ID: 2019792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet rich concentrate: basic science and current clinical applications.
    Mehta S; Watson JT
    J Orthop Trauma; 2008 Jul; 22(6):432-8. PubMed ID: 18594311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is platelet-rich plasma the perfect enhancement factor? A current review.
    Sánchez AR; Sheridan PJ; Kupp LI
    Int J Oral Maxillofac Implants; 2003; 18(1):93-103. PubMed ID: 12608674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of growth factors in flexor tendon wound healing.
    Hsu C; Chang J
    J Hand Surg Am; 2004 Jul; 29(4):551-63. PubMed ID: 15249076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells.
    Humes HD; Beals TF; Cieslinski DA; Sanchez IO; Page TP
    Lab Invest; 1991 Apr; 64(4):538-45. PubMed ID: 2016859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants.
    Garg AK
    Dent Implantol Update; 2000 Mar; 11(3):17-21. PubMed ID: 11992937
    [No Abstract]   [Full Text] [Related]  

  • 36. Biologically active mediators: platelet-derived growth factor, monocyte chemoattractant protein-1, and transforming growth factor-beta.
    Graves DT; Cochran DL
    Curr Opin Dent; 1991 Dec; 1(6):809-15. PubMed ID: 1807487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biology of platelet-derived growth factor.
    Ross R; Raines EW; Bowen-Pope DF
    Cell; 1986 Jul; 46(2):155-69. PubMed ID: 3013421
    [No Abstract]   [Full Text] [Related]  

  • 38. The growth factor-platelet-transformation connection.
    Bowen-Pope DF
    Dev Biol (N Y 1985); 1986; 3():111-28. PubMed ID: 3077960
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet gel for healing cutaneous chronic wounds.
    Crovetti G; Martinelli G; Issi M; Barone M; Guizzardi M; Campanati B; Moroni M; Carabelli A
    Transfus Apher Sci; 2004 Apr; 30(2):145-51. PubMed ID: 15062754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived endothelial cell growth factor.
    Heldin CH; Usuki K; Miyazono K
    J Cell Biochem; 1991 Nov; 47(3):208-10. PubMed ID: 1724243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.